The Oregon Alzheimer's Disease Center's (OADC) goal is to facilitate and advance research on Alzheimer's disease (AD) and related topics, concentrating our efforts to better define normal aging, the transitions to mild cognitive impairment (MCI) and early dementia. This will be achieved by maintaining five core facilities in association with expert core personnel to support current research strengths and to be responsive to new knowledge and discoveries in the field. The OADC is oordinated to be an efficient unit, working in concert with the research community to facilitate investigation in several major thematic areas such as studies of incipient dementia in the very elderly, the genetics of healthy brain aging, biomarkers of underlying disease, and alternative treatment regimens. The Clinical Core provides well characterized, longitudinally followed research subjects of several kinds: 1) early AD and related dementias; 2) non-cognitively impaired or MCI elderly at high risk for developing dementia, emphasizing the oldest old; and 3) subjects reflecting social and racial diversity (African American, Native American, and isolated rural populations). The Neuropathology Core is notably organized to maximize standardized diagnosis, availability of normative tissue, and research collaboration through the new Pacific Northwest Dementia and Aging (PANDA) Neuropathology Group, a cooperative effort of the OADC and University of Washington ADC Neuropathology Cores. The Genetics Core responds to the needs of this research with sophisticated characterization of research subjects and tissues by family history and genotype. The Genetics Core uniquely informs this research by creating a genomic resource for healthy brain aging. The Data Management and Statistics Core links all units with an efficient relational database creating a seamless pathway to ongoing and future collaborations with the National Alzheimer's Coordinating Center and other ADCs. The Data Core also provides important assistance and advice in design and statistical analysis to investigators. New information and knowledge of the field is disseminated through the Education and Information Transfer Core. This core uses a variety of educational forums ranging from small seminars to web-based information dissemination. The core's professional education programs emphasize empowering primary care providers to meet the challenge of insuring optimal brain aging for our senior population.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG008017-17
Application #
7066509
Study Section
Special Emphasis Panel (ZAG1-ZIJ-8 (J1))
Program Officer
Phelps, Creighton H
Project Start
1997-01-01
Project End
2010-03-31
Budget Start
2006-05-15
Budget End
2007-03-31
Support Year
17
Fiscal Year
2006
Total Cost
$1,188,310
Indirect Cost
Name
Oregon Health and Science University
Department
Neurology
Type
Schools of Medicine
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487
Wardzala, Casia; Murchison, Charles; Loftis, Jennifer M et al. (2018) Sex differences in the association of alcohol with cognitive decline and brain pathology in a cohort of octogenarians. Psychopharmacology (Berl) 235:761-770
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Besser, Lilah; Kukull, Walter; Knopman, David S et al. (2018) Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set. Alzheimer Dis Assoc Disord 32:351-358
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416

Showing the most recent 10 out of 482 publications